Loading...
SYNLAB AG
SYAB.DE•XETRA
HealthcareMedical - Diagnostics & Research
€11.06
€-0.02(-0.18%)
SYNLAB AG (SYAB.DE) Stock Overview
Explore SYNLAB AG’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for SYAB.DEStats details for SYAB.DE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for SYAB.DEAnalyst Recommendations details for SYAB.DE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers Coronavirus tests, and medical and veterinary diagnostics services. It operates through approximately 500 laboratories and 1,800 blood collection points in 36 countries in four continents. The company was founded in 1998 and is headquartered in Munich, Germany.
CEO
Mr. Mathieu Floreani
Employees
27,000
Headquarters
Moosacher Straße 88, Munich
Founded
2021